Pain Management

A recent trial of a humanised monoclonal antibody has shown potential in the preventative treatment of migraines in chronic migraine sufferers. It is hoped that the drug can be used to treat the notoriously debilitating Cluster headaches. Fremanezumab is in the class of drugs that block the CGRP pathway. Other drugs with this mechanism of action already on the market include Eptinezumab, Erenumab and Galcanezumab. The new treatment centres around the use of a humanised monoclonal antibody known as Frumenezumab to target…

Managing and otherwise minimising pain and suffering of patients is a core responsibility of providing nursing care. Minimising pain makes life significantly more comfortable for the patient, and allows them to recover faster, and with a positive experience. Unfortunately, this isn’t always the case, and when nurses fail to read the signs of pain and do not provide remedial action, the patients are the ones that suffer greatly. The complexity of a patients condition and comorbidities can obscure significant problems in the…